Press Releases

January 11th, 2016

HemoShear Therapeutics Announces Next Stage Of Safety Collaboration With Pfizer Inc.

Read More »
January 6th, 2016

HemoShear Therapeutics Races Toward Discovery Of Treatments For Children's Rare Diseases

Read More »
December 21st, 2015

HemoShear Therapeutics And Children's National Medical Center Co-Present In The Middle East On Rare Metabolic Disorders

Read More »
November 24th, 2015

HemoShear Therapeutics Names H. Thomas Watkins To Board Of Directors

Read More »
November 12th, 2015

HemoShear Therapeutics, LLC To Present Data On Its Drug Discovery Platform At The American Association For The Study Of Liver Diseases

Read More »
July 9th, 2015

HemoShear Therapeutics Names Robert Gould To Board Of Directors

Read More »
June 15th, 2015

HemoShear Expands Focus To Discovery Of Therapeutics

Read More »
January 12th, 2015

HemoShear Announces Collaboration With Pfizer Inc. To Help Identify And Predict Drug-Induced Vascular Injury For Early Stage Compounds

Read More »
November 17th, 2014

HemoShear And Children’s National Health System To Unveil New Paradigm For Accelerating Rare Disease Drug Discovery

Read More »
June 18th, 2014

HemoShear Wins A National 2014 Tibbetts SBIR Award From The Small Business Administration

Read More »

Contact

info@hemoshear.com

501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902